Biochem/physiol Actions
BAY-8002 is an orally available, potent and selective inhibitor of lactate transporter MCT1 (monocarboxylate transporter 1; SLC16A1) that potently inhibits bidirectional lactate transport. BAY-8002 exhibits antiproliferative activity in numerous cancer cell lines. BAY-8002 induces accumulation of lactate and significantly inhibits tumor growth in mice model. It does not cause tumor regression.
- UPC:
- 42295109
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML2670-25MG
- CAS:
- 724440-27-1
akash.verma@cenmed.com
(732) 447-1115





